RNXT

Conviction 33HealthcareScan · Thu, Jun 25, 2026

RNXT$0.9330-2.10%

ResistanceSupportVol 14Insider buy

Vol MA14 256.14K

Mar 26Apr 14May 1May 19Jun 8Jun 25

RenovoRx, Inc.PHARMACEUTICAL PREPARATIONSwww.renovorx.com ↗

Price0.9330

Change-2.10%

Gap+1.14%

Rel volume1.95×

Avg volume312.97K

Avg $ vol287.34K

SMA 200.9035

SMA 500.8945

SMA 2000.9815

Price vs 50+4.30%

Price vs 200-4.95%

MA stackmixed

50/200 cross—

Supertrendup · 0.7866

RSI (14)55

MACD hist0.01

MACD crossbull · 4d

Stoch %K / %D62 / 61

ADX (14)23

+DI / −DI21 / 9

RSI divergence—

MACD divergence—

ATR %+6.03%

ADR %6.63%

52w high1.40

52w low0.7325

From 52w high-33.36%

Above 52w low+27.37%

New 52w highNo

SqueezeOn · 6d

Bollinger width16.76%

%B0.69

Donchian pos61.82%

Donchian high0.9900

Donchian low0.8407

AVWAP (52w high)1.04

vs AVWAP high-10.19%

AVWAP (52w low)0.9444

vs AVWAP low-1.21%

OBV trendUp

Chaikin MF (20)-0.16

Today vs 20d1.95×

Avg vol (14d)256.14K

Avg vol (20d)312.97K

Avg $ vol (20d)287.34K

Market cap42.08M

RS 3m (vs SPY)-24.02%

RS 6m (vs SPY)-5.26%

RS line new highNo

Trend template1/8

Technical rank50.8

1 week+4.75%

1 month+1.88%

3 months-15.18%

6 months+3.67%

1 year-34.30%

YTD+11.71%

P/E-3.77

P/B3.74

P/S37.47

P/FCF-3.83

EPS-0.3200

Div yield—

ROE-99.14%

ROA-79.98%

Debt/Eq—

Current7.15

EV/EBITDA-2.83

Gross margin70.88%

Net margin-994.48%

Rev growth2511.63%

EPS growth-26.71%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value29.72M

Revenue563K

Net income-3.52M

Gross profit479K

Free cash flow-10.97M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out45.1M

Employees17

ListedThu, Aug 26, 2021

Free float38.91M

Float %86.4%

Short interest416.17K

Days to cover1.2d

Short volume45.7%

Squeeze score26 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction33 / 100

Pattern quality—

Tech rank50.8 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.9900

Support0.8000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RNXT

All disclosures →

No recent disclosed trades by Congress in RNXT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RNXT · 1 buy

Insider	Side	Shares	Value	Traded	Filed
VOLL MARK Chief Financial Officer · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
VOLL MARK Chief Financial Officer · Common Stock · 2026-05-19	Buy	25K	$20K	2026-05-19	2026-05-21

SEC filings

EDGAR filings in RNXT

EDGAR →

No recent SEC filings on file for RNXT.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.